Page 27 - JCBP-3-1

Journal of Clinical and
Basic Psychosomatics Somatic symptom disorder etiology

126. Bannon AW, Decker MW, Holladay MW, et al. Broad- Opin Ther Targets. 2007;11:891-897.
spectrum, non-opioid analgesic activity by selective
modulation of neuronal nicotinic acetylcholine receptors. doi: 10.1517/14728222.11.7.891
Science. 1998;279:77-81. 130. Vincler M, Wittenaur S, Parker R, Ellison M, Olivera BM,
McIntosh JM. Molecular mechanism for analgesia involving
doi: 10.1126/science.279.5347.77
specific antagonism of alpha9alpha10 nicotinic acetylcholine
127. Di Cesare Mannelli L, Ghelardini C, Calvani M, et al. receptors. Proc Natl Acad Sci U S A. 2006;103(47):17880-17884.
Neuroprotective effects of acetyl-L-carnitine on neuropathic
pain and apoptosis: A role for the nicotinic receptor. doi: 10.1073/pnas.0608715103
J Neurosci Res. 2009;87:200-207. 131. Amat J, Dolzani SD, Tilden S, et al. Previous ketamine
doi: 10.1002/jnr.21815 produces an enduring blockade of neurochemical and
behavioral effects of uncontrollable stress. J Neurosci
128. Coutinho MR, Menescal-de-Oliveira L. Role of 2016;36:153-161.
homocysteic acid in the guinea pig (Cavia porcellus)
anterior cingulate cortex in tonic immobility and the doi: 10.1523/JNEUROSCI.3114-15.2016
influence of NMDA receptors on the dorsal PAG. Behav 132. Nwokafor C, Serova LI, Sabban EL. Preclinical findings
Brain Res. 2010;208:237-242. on the potential of intranasal neuropeptide Y for treating
doi: 10.1016/j.bbr.2009.11.047 hyperarousal features of PTSD. Ann N Y Acad Sci.
2019;1455(1):149-159.
129. Vincler M, McIntosh JM. Targeting the alpha9alpha10
nicotinic acetylcholine receptor to treat severe pain. Expert doi: 10.1111/nyas.14172

Volume 3 Issue 1 (2025) 21 doi: 10.36922/jcbp.4254